We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Adaptimmune Announces Opening of Phase I/II Clinical Trial for Metastatic Melanoma

News   Jun 20, 2011

 
Adaptimmune Announces Opening of Phase I/II Clinical Trial for Metastatic Melanoma
 
 
Advertisement
 

RELATED ARTICLES

Preventing Certain Skin Cancers With a Common Drug

News

New data from preclinical studies suggests that an oral drug currently used in the clinical setting to treat neuromuscular diseases could also help to prevent a common form of skin cancer caused by damage from ultraviolet-B radiation.

READ MORE

Editing a Mosquito’s Gut Genes To Make Them Spread Antimalarial Genes

News

Altering a mosquito’s gut genes to make them spread antimalarial genes to the next generation of their species shows promise as an approach to curb malaria, suggests a preliminary study published today in eLife.

READ MORE

Intestinal Organoids Show How SARS-CoV-2 Affects the Gut

News

BU researchers have created human induced pluripotent stem cell-derived intestinal organoids that can be infected with SARS-CoV-2.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE